nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Advances in receptor chromatography for drug discovery and drug–receptor interaction studies
|
Fu, Jia |
|
|
28 |
6 |
p. |
artikel |
2 |
AlphaFold, allosteric, and orthosteric drug discovery: Ways forward
|
Nussinov, Ruth |
|
|
28 |
6 |
p. |
artikel |
3 |
Carbon nanosheets to unravel the production of bioactive compounds from microalgae: A robust approach in drug discovery
|
Agarwal, Aakanksha |
|
|
28 |
6 |
p. |
artikel |
4 |
Computer-aided drug design in seeking viral capsid modulators
|
Zhao, Shujie |
|
|
28 |
6 |
p. |
artikel |
5 |
Contents page
|
|
|
|
28 |
6 |
p. |
artikel |
6 |
COVID-19 therapeutics: Small-molecule drug development targeting SARS-CoV-2 main protease
|
Kronenberger, Thales |
|
|
28 |
6 |
p. |
artikel |
7 |
Demystifying the potential of inhibitors targeting DNA topoisomerases in unicellular protozoan parasites
|
Lamba, Swati |
|
|
28 |
6 |
p. |
artikel |
8 |
Driving the degradation of oncofusion proteins for targeted cancer therapy
|
Zhang, Xingya |
|
|
28 |
6 |
p. |
artikel |
9 |
Evaluation of clinical trial designs for novel anticancer drugs in China: A cohort study of drugs approved between 2015 and 2021
|
Luo, Xingxian |
|
|
28 |
6 |
p. |
artikel |
10 |
Expanding therapeutic potential of Bdellovibrio bacteriovorus against multidrug-resistant pathogens
|
Maurmann de Souza, Camila |
|
|
28 |
6 |
p. |
artikel |
11 |
Morphoceuticals: Perspectives for discovery of drugs targeting anatomical control mechanisms in regenerative medicine, cancer and aging
|
Pio-Lopez, Léo |
|
|
28 |
6 |
p. |
artikel |
12 |
Multidrug nanoformulations of vitamin D, anandamide and melatonin as a synergistic treatment for vascular inflammation
|
Martín Giménez, Virna Margarita |
|
|
28 |
6 |
p. |
artikel |
13 |
Nanomedicine-mediated therapeutic approaches for pulmonary arterial hypertension
|
Mirhadi, Elaheh |
|
|
28 |
6 |
p. |
artikel |
14 |
Nanostructured organic photosensitizer aggregates in disease phototheranostics
|
Zheng, Maochao |
|
|
28 |
6 |
p. |
artikel |
15 |
Pharmacological modulation of autophagy for epilepsy therapy: Opportunities and obstacles
|
Chen, Wenqing |
|
|
28 |
6 |
p. |
artikel |
16 |
Promise of dostarlimab in cancer therapy: Advancements and cross-talk considerations
|
Babar, Quratulain |
|
|
28 |
6 |
p. |
artikel |
17 |
Recent progress in covalent organic frameworks for cancer therapy
|
Khan, Nabab |
|
|
28 |
6 |
p. |
artikel |
18 |
RNA-binding proteins in cancer drug discovery
|
Bertoldo, Jean B. |
|
|
28 |
6 |
p. |
artikel |
19 |
Role of SIRT3 in mitochondrial biology and its therapeutic implications in neurodegenerative disorders
|
Mishra, Yogesh |
|
|
28 |
6 |
p. |
artikel |
20 |
Senolytics: Opening avenues in drug discovery to find novel therapeutics for Parkinson’s Disease
|
Kakoty, Violina |
|
|
28 |
6 |
p. |
artikel |
21 |
Small-molecule modulators of tumor necrosis factor signaling
|
Chédotal, Henri |
|
|
28 |
6 |
p. |
artikel |
22 |
Small pharma vendor management practices in clinical trials: A case study within Faron Pharmaceuticals
|
Williamson, Joab |
|
|
28 |
6 |
p. |
artikel |
23 |
The ethics of animal research and testing: A US perspective
|
Maciejewski, Eva C. |
|
|
28 |
6 |
p. |
artikel |
24 |
Treatment alternatives for multidrug-resistant fungal pathogens
|
Roe, Kevin |
|
|
28 |
6 |
p. |
artikel |